American Society of Hematology

Fig. 1.

$Fig. 1. Schematic representation of treatment protocol. / Patients with relapsed or refractory NHL or HD who were eligible for autologous transplantation were randomized to receive G-CSF alone or cyclophosphamide (5 g/m2) and G-CSF for HPC mobilization after salvage therapy with CEPP. All patients received the same dose of cyclophosphamide, followed by etoposide, before autologous transplantation. Involved field radiotherapy was given for bulky disease (mass greater than 5 cm).$

Schematic representation of treatment protocol.

Patients with relapsed or refractory NHL or HD who were eligible for autologous transplantation were randomized to receive G-CSF alone or cyclophosphamide (5 g/m²) and G-CSF for HPC mobilization after salvage therapy with CEPP. All patients received the same dose of cyclophosphamide, followed by etoposide, before autologous transplantation. Involved field radiotherapy was given for bulky disease (mass greater than 5 cm).

This Feature Is Available To Subscribers Only